# Surgical Outcomes in Non-Transected and Partially Transected Peripheral Nerve Injuries

**Authors:** Naveen Arunachalam Sakthiyendran, Karter Morris, Caroline J. Cushman, Evan J. Hernandez, Anceslo Idicula, Brendan J. MacKay

PMC · DOI: 10.3390/brainsci15111202 · Brain Sciences · 2025-11-07

## TL;DR

This paper reviews surgical outcomes for non-transected and partially transected peripheral nerve injuries, offering guidance on optimal treatment strategies and factors affecting recovery.

## Contribution

The study provides a systematic review and case illustration to clarify surgical management and outcomes for understudied peripheral nerve injuries.

## Key findings

- Neurolysis of NAP-positive lesions often restores antigravity strength, with ~75% recovery from direct repair or grafting of nonconductive segments.
- Brachial plexus/axillary neuromas-in-continuity show ~77–92% improvement after neurolysis or reconstruction.
- Earlier intervention, shorter gaps, and younger age correlate with better outcomes, while prolonged observation risks end-organ atrophy.

## Abstract

Background: Non-transected and partially transected peripheral nerve injuries (neuromas-in-continuity) are relatively common but understudied. Their optimal surgical management and expected outcomes remain unclear. We conducted a literature review of surgical repairs in such lesions and illustrate a case to guide decision-making. Systematic searches of PubMed and Google Scholar identified 70 eligible reports (Level I = 2, Level II = 5, Level III = 37, Level IV = 20, Level V = 4). Across studies, neurolysis of NAP-positive lesions often restored antigravity strength, while direct repair or grafting of nonconductive segments yielded meaningful recovery in ~75%. After neurolysis or reconstruction, ~77–92% of brachial plexus/axillary neuromas-in-continuity reached LSUHSC Grade ≥3. Median/ulnar lesions treated with neurolysis, biologic/vascularized coverage, or reconstruction showed reliable pain relief but variable sensory/motor recovery. Radial/PIN lesions improved in some series irrespective of NAPs. Earlier intervention, shorter gaps, distal sites, and younger age correlated with superior outcomes. Meanwhile, prolonged observation risking end-organ atrophy degraded results. Adjuncts such as electrical stimulation and wraps may aid reinnervation or reduce scarring, though high-quality evidence is limited. Conclusions: For non-transected and partially transected PNIs, a pragmatic approach emerges: Observe low-grade injuries with serial examinations. Explore early if recovery stalls (≈3–6 months). Use NAP-guided neurolysis for conductive lesions. Perform tension-free repair or grafting for nonconductive segments, adding anti-adhesive coverage when appropriate. Standardized reporting and prospective trials are needed to refine timing, technique selection, and patient-reported outcomes.

## Full-text entities

- **Genes:** CTNNBL1 (catenin beta like 1) [NCBI Gene 56259] {aka C20orf33, IMD99, NAP, P14L, PP8304, dJ633O20.1}
- **Diseases:** neuromas (MESH:D009463), pain (MESH:D010146), atrophy (MESH:D001284), Peripheral Nerve Injuries (MESH:D059348), lesions (MESH:D009059)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12651499/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12651499/full.md

## References

91 references — full list in the complete paper: https://tomesphere.com/paper/PMC12651499/full.md

---
Source: https://tomesphere.com/paper/PMC12651499